Nucarnit 500mg Tablets | 100-Count | LEVOCARNITINE

🇮🇳 India Warehouse
LEVOCARNITINE — 500mg per tablet, 100-count pack.
L-carnitine for carnitine deficiency (primary genetic, or secondary to valproate or renal dialysis). Off-label for athletic performance, fatigue, cardiac conditions, and male fertility.

Key warning: Fishy body odor from intestinal TMAO production — discuss with patients. TMAO theoretical cardiovascular concern at very high doses (controversial). Seizure risk at high doses in epilepsy patients.

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.

{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What is Nucarnit 500mg used for?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”L-carnitine for carnitine deficiency (primary genetic, or secondary to valproate or renal dialysis). Off-label for athletic performance, fatigue, cardiac conditions, and male fertility.”}},{“@type”:”Question”,”name”:”What are the side effects of LEVOCARNITINE?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”GI effects (nausea, diarrhea, abdominal cramps), fishy body odor (trimethylamine production). Seizure threshold lowering at high doses.”}},{“@type”:”Question”,”name”:”Where does this ship from?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Ships from India Warehouse — international delivery worldwide.”}}]}

What is Nucarnit 500mg (LEVOCARNITINE)?

L-carnitine for carnitine deficiency (primary genetic, or secondary to valproate or renal dialysis). Off-label for athletic performance, fatigue, cardiac conditions, and male fertility.

How it Works

Essential cofactor for transport of long-chain fatty acids into mitochondria for energy production. Also buffers toxic acyl-CoA compounds and modulates energy metabolism.

Quick Specs

Form Oral tablets — pre-dosed
Active Ingredient LEVOCARNITINE
Dose per Tablet 500MG
Pack Size 10×10 (100 tablets)
Storage Room temperature (15–25°C), cool dry place
Shelf Life 2–3 years (properly stored)

Common Side Effects

GI effects (nausea, diarrhea, abdominal cramps), fishy body odor (trimethylamine production). Seizure threshold lowering at high doses.

Safety Warnings

⚠️ Fishy body odor from intestinal TMAO production — discuss with patients. TMAO theoretical cardiovascular concern at very high doses (controversial). Seizure risk at high doses in epilepsy patients.

🌏 International shipping: 7–14 days

Frequently asked questions

How does my subscription work?

A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.

How do I edit what's in my plan?

Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.

Can I change my next delivery date?

A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.

It's been a while since I took the quiz. Can I get a new recommendation?

Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Nucarnit 500mg Tablets | 100-Count | LEVOCARNITINE”

Your email address will not be published. Required fields are marked *